CN Stock MarketDetailed Quotes

603193 Runben Biotechnology

Watchlist
  • 17.42
  • -0.17-0.97%
Market Closed Sep 9 15:00 CST
7.05BMarket Cap24.60P/E (TTM)

Runben Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
Total operating revenue
28.47%744.03M
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
151.5M
47.06%856.09M
681.16M
438.98M
31.46%582.15M
Operating revenue
28.47%744.03M
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
--151.5M
47.06%856.09M
--681.16M
--438.98M
31.46%582.15M
Other operating revenue
7.35%402.3K
----
49.30%657.8K
----
121.93%374.76K
----
85.75%440.6K
----
--168.86K
38.51%237.2K
Total operating cost
22.33%537.56M
0.86%130.26M
14.78%772.61M
16.53%611.99M
26.53%439.43M
129.15M
51.14%673.14M
525.18M
347.29M
32.89%445.37M
Operating cost
19.55%307.76M
3.36%73.85M
14.99%450.93M
15.47%361.4M
26.23%257.44M
--71.45M
43.47%392.15M
--312.98M
--203.94M
30.03%273.34M
Operating tax surcharges
63.70%8.53M
59.00%2.49M
7.21%9.52M
14.24%7.72M
49.95%5.21M
--1.57M
30.02%8.88M
--6.75M
--3.47M
53.14%6.83M
Operating expense
38.23%213.79M
14.68%50.25M
15.88%268.74M
18.22%208.67M
28.80%154.66M
--43.82M
72.50%231.91M
--176.51M
--120.07M
41.33%134.44M
Administration expense
1.30%14.06M
2.82%7.19M
30.24%32.95M
9.70%20.29M
6.88%13.88M
--7M
20.74%25.3M
--18.49M
--12.99M
42.70%20.95M
Financial expense
-462.85%-21.33M
-3,262.73%-10.41M
-230.23%-15.21M
-17.42%-4.34M
-65.26%-3.79M
---309.6K
-21.80%-4.61M
---3.7M
---2.29M
-16,484.15%-3.78M
-Interest expense (Financial expense)
-57.00%69.12K
-59.71%38.12K
-40.20%256.3K
-34.41%203.02K
-29.58%160.77K
--94.62K
-20.25%428.6K
--309.53K
--228.3K
--537.47K
-Interest Income (Financial expense)
-435.50%-21.46M
-2,341.86%-10.46M
-203.16%-15.56M
-13.19%-4.63M
-56.90%-4.01M
---428.52K
-24.30%-5.13M
---4.09M
---2.55M
-7,095.32%-4.13M
Research and development
22.69%14.76M
22.26%6.88M
31.68%25.69M
29.13%18.26M
32.17%12.03M
--5.63M
43.46%19.51M
--14.14M
--9.1M
26.97%13.6M
Credit Impairment Loss
-747.78%-1.85M
-146.04%-425.58K
-320.14%-148.45K
38.90%-392.31K
31.83%-217.68K
---172.97K
-1,350.82%-35.33K
---642.04K
---319.33K
111.76%2.82K
Asset Impairment Loss
-930.84%-4.15M
-746.06%-2.51M
-113.42%-2.41M
63.55%-213.94K
32.43%-403.07K
---296.09K
53.10%-1.13M
---586.97K
---596.49K
-205.79%-2.41M
Adjustment items of total operating cost
----
----
----
--0.01
----
----
----
----
----
----
Other net revenue
-195.46%-1.52M
-4,205.82%-1.4M
49.78%4.27M
235.04%4.87M
75.19%1.59M
-32.56K
-30.66%2.85M
1.45M
907.19K
64.59%4.11M
Invest income
345.17%472.72K
731.16%151.35K
-59.05%838.63K
-58.10%499.65K
-86.09%106.19K
--18.21K
4.58%2.05M
--1.19M
--763.65K
162.27%1.96M
Asset deal income
-381.83%-236.92K
---210.51K
77.67%84.06K
--83.89K
--84.06K
--0
4,681.75%47.31K
----
----
--989.48
Other revenue
110.29%4.25M
279.59%1.59M
207.32%5.91M
228.34%4.89M
90.66%2.02M
--418.29K
-57.84%1.92M
--1.49M
--1.06M
107.02%4.56M
Operating profit
45.03%204.94M
56.91%35.02M
42.42%264.62M
37.46%216.4M
52.60%141.31M
22.32M
31.88%185.8M
157.43M
92.6M
27.88%140.89M
Add:Non operating Income
9,551.06%5.04M
41,541.59%5.03M
34.20%3.32M
-87.79%292.73K
-97.73%52.19K
--12.07K
146.38%2.47M
--2.4M
--2.3M
1,051.35%1M
Less:Non operating expense
5,495.12%9.84K
7,740.97%8.23K
1,687.20%10.73K
1,879.70%5.08K
430.07%175.93
--105.02
-99.77%600.4
--256.73
--33.19
1,503.21%259.52K
Total profit
48.54%209.97M
79.30%40.04M
42.31%267.93M
35.58%216.69M
48.96%141.36M
22.33M
32.93%188.27M
159.83M
94.9M
28.47%141.63M
Less:Income tax cost
36.79%29.94M
277.89%4.57M
48.43%41.9M
26.83%35.96M
33.87%21.89M
--1.21M
34.52%28.23M
--28.35M
--16.35M
35.12%20.98M
Net profit
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
131.48M
78.55M
27.38%120.65M
Net profit from continuing operation
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
--119.47M
--21.12M
32.66%160.04M
--131.48M
----
27.38%120.65M
Net profit of parent company owners
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
--131.48M
--78.55M
27.38%120.65M
Earning per share
Basic earning per share
25.71%0.44
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
--0.38
--0.23
16.13%0.36
Diluted earning per share
25.71%0.44
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
--0.38
--0.23
16.13%0.36
Other composite income
Total composite income
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
131.48M
78.55M
27.38%120.65M
Total composite income of parent company owners
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
--131.48M
--78.55M
27.38%120.65M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Unqualified opinion
Auditor
--
--
Guangdong Sinong Certified Public Accountants Firm (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021
Total operating revenue 28.47%744.03M10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M151.5M47.06%856.09M681.16M438.98M31.46%582.15M
Operating revenue 28.47%744.03M10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M--151.5M47.06%856.09M--681.16M--438.98M31.46%582.15M
Other operating revenue 7.35%402.3K----49.30%657.8K----121.93%374.76K----85.75%440.6K------168.86K38.51%237.2K
Total operating cost 22.33%537.56M0.86%130.26M14.78%772.61M16.53%611.99M26.53%439.43M129.15M51.14%673.14M525.18M347.29M32.89%445.37M
Operating cost 19.55%307.76M3.36%73.85M14.99%450.93M15.47%361.4M26.23%257.44M--71.45M43.47%392.15M--312.98M--203.94M30.03%273.34M
Operating tax surcharges 63.70%8.53M59.00%2.49M7.21%9.52M14.24%7.72M49.95%5.21M--1.57M30.02%8.88M--6.75M--3.47M53.14%6.83M
Operating expense 38.23%213.79M14.68%50.25M15.88%268.74M18.22%208.67M28.80%154.66M--43.82M72.50%231.91M--176.51M--120.07M41.33%134.44M
Administration expense 1.30%14.06M2.82%7.19M30.24%32.95M9.70%20.29M6.88%13.88M--7M20.74%25.3M--18.49M--12.99M42.70%20.95M
Financial expense -462.85%-21.33M-3,262.73%-10.41M-230.23%-15.21M-17.42%-4.34M-65.26%-3.79M---309.6K-21.80%-4.61M---3.7M---2.29M-16,484.15%-3.78M
-Interest expense (Financial expense) -57.00%69.12K-59.71%38.12K-40.20%256.3K-34.41%203.02K-29.58%160.77K--94.62K-20.25%428.6K--309.53K--228.3K--537.47K
-Interest Income (Financial expense) -435.50%-21.46M-2,341.86%-10.46M-203.16%-15.56M-13.19%-4.63M-56.90%-4.01M---428.52K-24.30%-5.13M---4.09M---2.55M-7,095.32%-4.13M
Research and development 22.69%14.76M22.26%6.88M31.68%25.69M29.13%18.26M32.17%12.03M--5.63M43.46%19.51M--14.14M--9.1M26.97%13.6M
Credit Impairment Loss -747.78%-1.85M-146.04%-425.58K-320.14%-148.45K38.90%-392.31K31.83%-217.68K---172.97K-1,350.82%-35.33K---642.04K---319.33K111.76%2.82K
Asset Impairment Loss -930.84%-4.15M-746.06%-2.51M-113.42%-2.41M63.55%-213.94K32.43%-403.07K---296.09K53.10%-1.13M---586.97K---596.49K-205.79%-2.41M
Adjustment items of total operating cost --------------0.01------------------------
Other net revenue -195.46%-1.52M-4,205.82%-1.4M49.78%4.27M235.04%4.87M75.19%1.59M-32.56K-30.66%2.85M1.45M907.19K64.59%4.11M
Invest income 345.17%472.72K731.16%151.35K-59.05%838.63K-58.10%499.65K-86.09%106.19K--18.21K4.58%2.05M--1.19M--763.65K162.27%1.96M
Asset deal income -381.83%-236.92K---210.51K77.67%84.06K--83.89K--84.06K--04,681.75%47.31K----------989.48
Other revenue 110.29%4.25M279.59%1.59M207.32%5.91M228.34%4.89M90.66%2.02M--418.29K-57.84%1.92M--1.49M--1.06M107.02%4.56M
Operating profit 45.03%204.94M56.91%35.02M42.42%264.62M37.46%216.4M52.60%141.31M22.32M31.88%185.8M157.43M92.6M27.88%140.89M
Add:Non operating Income 9,551.06%5.04M41,541.59%5.03M34.20%3.32M-87.79%292.73K-97.73%52.19K--12.07K146.38%2.47M--2.4M--2.3M1,051.35%1M
Less:Non operating expense 5,495.12%9.84K7,740.97%8.23K1,687.20%10.73K1,879.70%5.08K430.07%175.93--105.02-99.77%600.4--256.73--33.191,503.21%259.52K
Total profit 48.54%209.97M79.30%40.04M42.31%267.93M35.58%216.69M48.96%141.36M22.33M32.93%188.27M159.83M94.9M28.47%141.63M
Less:Income tax cost 36.79%29.94M277.89%4.57M48.43%41.9M26.83%35.96M33.87%21.89M--1.21M34.52%28.23M--28.35M--16.35M35.12%20.98M
Net profit 50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M131.48M78.55M27.38%120.65M
Net profit from continuing operation 50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M--119.47M--21.12M32.66%160.04M--131.48M----27.38%120.65M
Net profit of parent company owners 50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M--131.48M--78.55M27.38%120.65M
Earning per share
Basic earning per share 25.71%0.4450.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47--0.38--0.2316.13%0.36
Diluted earning per share 25.71%0.4450.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47--0.38--0.2316.13%0.36
Other composite income
Total composite income 50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M131.48M78.55M27.38%120.65M
Total composite income of parent company owners 50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M--131.48M--78.55M27.38%120.65M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion----Unqualified opinion
Auditor ----Guangdong Sinong Certified Public Accountants Firm (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)----Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg